Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethyl gallate is a small molecule polyphenolic compound that is the ethyl ester of gallic acid. It is used primarily as an **antioxidant food additive (E313)**, but is also studied for apoptosis induction, anti-proliferative, antibacterial, anti-inflammatory, and wound healing properties. It is naturally found in several plants and foods, including Terminalia chebula, walnuts, wine, and guava. In cell and animal studies, ethyl gallate shows anti-cancer effects, such as reducing the proliferation and invasion of breast cancer cells through modulation of pathways including inhibition of matrix metalloproteinases (MMP-2, MMP-9), suppression of the PI3K/Akt pathway, and downregulation of NF-κB. It also demonstrates wound healing effects via topical application and neuroprotective activity related to HIF-1α/EPO/VEGFA pathway modulation. Its therapeutic use in humans is not established; most evidence is preclinical[1][2][3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethyl gallate.